Share: Facebook Twitter LinkedIn
Activity Provided By:

Physicians’ Education Resource®, LLC

Advances In™ PAH Associated with Congenital Heart Disease (PAH-CHD): Designing New Treatment Strategies Backed by Better Disease Understanding

Access Activity

Overview / Abstract:

Target Audience
This online educational activity is directed toward cardiologists, pulmonologists, NPs, PAs, and RNs. Additional healthcare professionals involved in the management and treatment of patients with PAH-CHD will also be invited to participate in this activity.

Program Overview
Pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD) is a lethal and progressive disease in which prostacyclin, nitric oxide, and endothelin-1 pathways are disturbed and contribute to the pathophysiology of this disease. Undiagnosed or delayed diagnosis of PAH might lead to Eisenmenger syndrome (ES). Screening for PAH in patients with CHD and timely diagnosis can facilitate prompt treatment; promising medical therapies have recently been approved for the management of patients with PAH-CHD, bringing about hope for improved hemodynamics, exercise capacity, quality of life, and possibly, survival for this patient population.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Describe the latest theories of PAH-CHD pathogenesis
Discuss advances in the diagnostic and prognostic assessment of PAH-CHD
Determine appropriate treatment strategies for individual patients based on disease pathophysiology, disease severity, and risk assessments


Oct 12, 2022


Physician CME



Credits / Hours




Presenters / Authors / Faculty

Richard Channick, MD
Vallerie McLaughlin, MD

Sponsors / Supporters / Grant Providers

Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson.

Keywords / Search Terms

Relias LLC Relias, Free CME, PAH-CHD, CHD, PAH Free CE CME

Access Activity

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map